بدائل البحث:
large decrease » marked decrease (توسيع البحث), large increases (توسيع البحث), large degree (توسيع البحث)
1 levels » _ levels (توسيع البحث)
a large » _ large (توسيع البحث)
i large » _ large (توسيع البحث), via large (توسيع البحث), i larvae (توسيع البحث)
b large » _ large (توسيع البحث), _ larger (توسيع البحث)
large decrease » marked decrease (توسيع البحث), large increases (توسيع البحث), large degree (توسيع البحث)
1 levels » _ levels (توسيع البحث)
a large » _ large (توسيع البحث)
i large » _ large (توسيع البحث), via large (توسيع البحث), i larvae (توسيع البحث)
b large » _ large (توسيع البحث), _ larger (توسيع البحث)
-
121
Longer polyQ sequences decrease the nuclear localization of AR in the absence of hormone.
منشور في 2022الموضوعات: -
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
SURF6 knockdown affects cell cycle distribution of HCT116 human intestinal carcinoma cells.
منشور في 2023الموضوعات: -
132
-
133
SURF6 co-localizes with ITS2 part of pre-rRNA in the nucleoli of HeLa cells.
منشور في 2023الموضوعات: -
134
-
135
-
136
-
137
-
138
Table1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.docx
منشور في 2024"…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). …"
-
139
Image1_Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy.JPEG
منشور في 2024"…Background<p>CDGSH iron-sulfur domain 2 (CISD2), an iron-sulfur protein with a [2Fe-2S] cluster, plays a pivotal role in the progression of various cancers, including Diffuse Large B-cell Lymphoma (DLBCL). …"
-
140
DataSheet_1_Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.xlsx
منشور في 2021"…The genes most frequently altered (> 20%) were (in decreasing order of frequency) CDKN2A, PIM1, CD79B, TP53, MYD88, MYC, BTG2, BTG1, CDKN2B, DTX1, CD58, ETV6, and IRF4. …"